WHF 2025 goal - premature mortality from cardiovascular disease - 25% reduction

Welcome to the World Heart Federation

Champion Advocates Programme

The aim of the Champion Advocates Programme is to reduce premature deaths caused by cardiovascular disease (CVD) by 25% by 2025. It’s an ambitious goal and to achieve it we are engaging with:

Cardiologists and other healthcare professionals, to become advocates of best evidence-based secondary prevention and treatment of heart disease and stroke.

Journalists, to help build awareness and media coverage of CVD as preventable and to influence national policy.

Emerging leaders, to help drive the global CVD agenda, promoting best practice, influencing national policy and strengthening health systems' responses to CVD.

Working together, we can prolong the lives of people around the globe, help reduce the financial burden of CVD on national health services and set the political agenda for CVD for decades to come.

To join our fight against premature mortality caused by CVD, including heart disease and stroke, and to access useful materials for health professionals and journalists, please register with the Champion Advocates Programme today.

Latest News

  • Johanna Ralston highlights key themes, events and announcements from WCC 2016

    Last week the World Heart Federation had the honour of hosting our biennial World Congress of Cardiology & Cardiovascular Health in Mexico City. Thank you to everyone - from our event organizers and hosts to our esteemed speakers, delegates, exhibitors, sponsors and, of course, WHF members - for making the event so stimulating and inspiring. It was wonderful to see the cardiovascular community coming together around our shared goal of a 25% reduction in premature mortality from cardiovascular disease by 2025.

    Read on

Upcoming Events

  • Emerging Leaders Applications 2015 NOW OPEN

    The Emerging Leaders Programme has been created by the World Heart Federation to form and develop a long-term cadre of experts who collaborate, research, and act to reduce premature mortality from cardiovascular disease (CVD) globally by at least 25% by 2025. The programme is supported by unrestricted educational grant from Boehringer Ingelheim. If you are interested in applying, please click here. Applications are accepted from 1st – 30th September.